AJR Join ARRS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Herbay, A.
Right arrow Articles by Häussinger, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Herbay, A.
Right arrow Articles by Häussinger, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
AJR 2002; 179:1273-1279
© American Roentgen Ray Society


Late-Phase Pulse-Inversion Sonography Using the Contrast Agent Levovist: Differentiation Between Benign and Malignant Focal Lesions of the Liver

Alexandra von Herbay1, Christoph Vogt and Dieter Häussinger

1 All authors: Department of Medicine and Department of Hepatology, Gastroenterology and Infectious Diseases, University of Düsseldorf, Moorenstr. 5, D-40225 Düsseldorf, Germany.

OBJECTIVE. We assessed the ability of contrast-enhanced sonography to reveal differences between benign and malignant focal hepatic lesions.

SUBJECTS AND METHODS. We examined 67 patients with focal hepatic lesions in a prospective study. The causes of the lesions were confirmed by histology, CT, MR imaging, or scintigraphy. The liver was screened for focal lesions using sonography. Thereafter, 2 g of Levovist (300 mg/mL; 1 mL/sec) was injected IV as a bolus. After a delay of at least 2.5 min without scanning, the liver was examined via three different scans using pulse-inversion sonography.

RESULTS. For the discrimination of malignant versus benign liver lesions, contrast-enhanced sonography improved sensitivity from 85% to 100% and specificity from 30% to 63%, as compared with baseline sonography. Receiver operating characteristic analysis revealed a significant improvement in this discrimination (Az = 0.692 ± 0.065 at baseline sonography, Az = 0.947 ± 0.037 with contrast-enhanced sonography, p < 0.001). Furthermore, a lower interobserver variability was found for contrast-enhanced sonography (weighted {kappa} = 0.947), as compared with baseline sonography (weighted {kappa} = 0.469). All lesions that had homogeneous enhancement in the late phase of Levovist enhancement were benign. In distinction, 90% of lesions without contrast enhancement in the late phase were malignant. All lesions were malignant that were isoechoic (invisible) on baseline sonography but visible because of lack of enhancement after injection.

CONCLUSION. Contrast-enhanced sonography has greater specificity and sensitivity than baseline sonography for the differentiation of benign and malignant liver lesions.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
E. Quaia, A. Palumbo, S. Rossi, F. Degobbis, S. Cernic, G. Tona, and M. Cova
Comparison of visual and quantitative analysis for characterization of insonated liver tumors after microbubble contrast injection.
Am. J. Roentgenol., June 1, 2006; 186(6): 1560 - 1570.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
C. Nicolau, R. Vilana, V. Catala, L. Bianchi, R. Gilabert, A. Garcia, and C. Bru
Importance of Evaluating All Vascular Phases on Contrast-Enhanced Sonography in the Differentiation of Benign from Malignant Focal Liver Lesions
Am. J. Roentgenol., January 1, 2006; 186(1): 158 - 167.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
K. Takeshima, T. Kumada, H. Toyoda, S. Kiriyama, M. Tanikawa, H. Ichikawa, T. Kawachi, and S. Ogawa
Comparison of IV Contrast-Enhanced Sonography and Histopathology of Pancreatic Cancer
Am. J. Roentgenol., November 1, 2005; 185(5): 1193 - 1200.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
C F Dietrich, G Schuessler, J Trojan, C Fellbaum, and A Ignee
Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound
Br. J. Radiol., August 1, 2005; 78(932): 704 - 707.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
H Maruyama, S Matsutani, H Saisho, Y Mine, N Kamiyama, T Hirata, and M Sasamata
Real-time blood-pool images of contrast enhanced ultrasound with Definity in the detection of tumour nodules in the liver
Br. J. Radiol., June 1, 2005; 78(930): 512 - 518.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
S. H. Kim, J. M. Lee, J. Y. Lee, J. K. Han, S. K. An, C. J. Han, K. H. Lee, S. S. Hwang, and B. I. Choi
Value of Contrast-Enhanced Sonography for the Characterization of Focal Hepatic Lesions in Patients with Diffuse Liver Disease: Receiver Operating Characteristic Analysis
Am. J. Roentgenol., April 1, 2005; 184(4): 1077 - 1084.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
O. Catalano, A. Nunziata, R. Lobianco, and A. Siani
Real-Time Harmonic Contrast Material-specific US of Focal Liver Lesions
RadioGraphics, March 1, 2005; 25(2): 333 - 349.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
H. Celik, H. Ozdemir, C. Yucel, S. Gultekin, S. O. Oktar, and M. Arac
Characterization of Hyperechoic Focal Liver Lesions: Quantitative Evaluation With Pulse Inversion Harmonic Imaging in the Late Phase of Levovist
J. Ultrasound Med., January 1, 2005; 24(1): 39 - 47.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
A. von Herbay, C. Vogt, R. Willers, and D. Haussinger
Real-time Imaging With the Sonographic Contrast Agent SonoVue: Differentiation Between Benign and Malignant Hepatic Lesions
J. Ultrasound Med., December 1, 2004; 23(12): 1557 - 1568.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
A. Giorgio, G. Ferraioli, L. Tarantino, G. de Stefano, V. Scala, F. Scarano, C. Coppola, and L. Del Viscovo
Contrast-Enhanced Sonographic Appearance of Hepatocellular Carcinoma in Patients with Cirrhosis: Comparison with Contrast-Enhanced Helical CT Appearance
Am. J. Roentgenol., November 1, 2004; 183(5): 1319 - 1326.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
T. H. Bryant, M. J. Blomley, T. Albrecht, P. S. Sidhu, E. L. S. Leen, R. Basilico, J. M. Pilcher, L. H. Bushby, C. W. Hoffmann, C. J. Harvey, et al.
Improved Characterization of Liver Lesions with Liver-Phase Uptake of Liver-specific Microbubbles: Prospective Multicenter Study
Radiology, September 1, 2004; 232(3): 799 - 809.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
V. Migaleddu, G. Virgilio, D. Turilli, M. Conti, G. Campisi, N. Canu, D. Sirigu, and I. Vincentelli
Characterization of Focal Liver Lesions in Real Time Using Harmonic Imaging with High Mechanical Index and Contrast Agent Levovist
Am. J. Roentgenol., June 1, 2004; 182(6): 1505 - 1512.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
C F Dietrich, A Ignee, J Trojan, C Fellbaum, and G Schuessler
Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A
Gut, March 1, 2004; 53(3): 401 - 405.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Emoto, R. Fujimitsu, H. Iwasaki, and T. Kawarabayashi
Diagnostic Challenges in Patients With Tumors: CASE 3. NORMAL-SIZED OVARIAN CANCER DETECTED BY COLOR DOPPLER ULTRASOUND USING A MICROBUBBLE CONTRAST AGENT
J. Clin. Oncol., October 1, 2003; 21(19): 3703 - 3705.
[Full Text] [PDF]


Home page
J Ultrasound MedHome page
A. von Herbay, C. Vogt, and D. Haussinger
Pulse Inversion Sonography in the Early Phase of the Sonographic Contrast Agent Levovist: Differentiation Between Benign and Malignant Focal Liver Lesions
J. Ultrasound Med., November 1, 2002; 21(11): 1191 - 1200.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Roentgen Ray Society.